Moreover, intracerebroventricular injection of IGF1 improves glucose tolerance and insulin sensitivity in mice (Hong et al., 2017), which further enhanced the relationship between AD and cerebral insulin sensitivity. The gene discussed is INS; the disease is Alzheimer disease.